Ahmad M, Tahir M, Hong Z, Zia M, Rafeeq H, Ahmad M
Front Pharmacol. 2025; 15():1497668.
PMID: 39834812
PMC: 11743463.
DOI: 10.3389/fphar.2024.1497668.
Alugoju P, Palanisamy C, Anthikapalli N, Jayaraman S, Prasanskulab A, Chuchawankul S
F1000Res. 2025; 12():1265.
PMID: 39822944
PMC: 11736113.
DOI: 10.12688/f1000research.141669.2.
Dong Y, Chen L, Wu H, Xie L, Yu J, Yang F
Molecules. 2024; 29(23).
PMID: 39683797
PMC: 11643544.
DOI: 10.3390/molecules29235639.
Zhang Z, Zhang L, Wu P, Tian Y, Wen Y, Xu M
Foods. 2024; 13(23).
PMID: 39682950
PMC: 11640417.
DOI: 10.3390/foods13233878.
Chen X, Chen Y, Xie J, Fu J, Zhang X
J Thorac Dis. 2024; 16(11):7526-7538.
PMID: 39678884
PMC: 11635222.
DOI: 10.21037/jtd-24-781.
Semi-synthesis of a DNA-Tagged Polyketide-Peptide Hybrid Macrocycle Using a Biosynthetically Prepared Fungal Macrolide as a Synthetic Component.
Koremura S, Sugawara A, Morishita Y, Ozaki T, Asai T
Org Lett. 2024; 26(42):9151-9156.
PMID: 39415106
PMC: 11519919.
DOI: 10.1021/acs.orglett.4c03588.
Larvicidal activity, molecular docking, and molecular dynamics studies of 7-(trifluoromethyl)indolizine derivatives against Anopheles arabiensis.
Singh H, Tiwari P, Deb P, Rakshit G, Maity P, Mohanlall V
Mol Divers. 2024; .
PMID: 39377893
DOI: 10.1007/s11030-024-10994-7.
The role of GZMA as a target of cysteine and biomarker in Alzheimer's disease, pelvic organ prolapse, and tumor progression.
Li Y, Wang Z, Kong M, Yong Y, Yang X, Liu C
Front Pharmacol. 2024; 15:1447605.
PMID: 39228516
PMC: 11368878.
DOI: 10.3389/fphar.2024.1447605.
Discovery of a novel pyrido[1,2-a]thiazolo[5,4-d]pyrimidinone derivatives with excellent potency against acetylcholinesterase.
Zeng Y, Chen Z, Yang Z, Yuan F, Nie L, Niu C
Mol Divers. 2024; .
PMID: 38935303
DOI: 10.1007/s11030-024-10920-x.
Biosynthesis and Anticancer Activity of Genistein Glycoside Derivatives.
Zheng X, Zhang J, Liu S, Yu Y, Peng Q, Peng Y
Anticancer Agents Med Chem. 2024; 24(13):961-968.
PMID: 38639281
DOI: 10.2174/0118715206299272240409043726.
A Compact Reprogrammed Genetic Code for De Novo Discovery of Proteolytically Stable Thiopeptides.
Vinogradov A, Zhang Y, Hamada K, Kobayashi S, Ogata K, Sengoku T
J Am Chem Soc. 2024; 146(12):8058-8070.
PMID: 38491946
PMC: 10979747.
DOI: 10.1021/jacs.3c12037.
Antibacterial insights into alternariol and its derivative alternariol monomethyl ether produced by a marine fungus.
Li R, Su Z, Sun C, Wu S
Appl Environ Microbiol. 2024; 90(4):e0005824.
PMID: 38470179
PMC: 11022538.
DOI: 10.1128/aem.00058-24.
Natural flavonoids as potential therapeutics in the management of Alzheimer's disease: a review.
Nguyen-Thi P, Vo T, Pham T, Nguyen T, Van Vo G
3 Biotech. 2024; 14(3):68.
PMID: 38357675
PMC: 10861420.
DOI: 10.1007/s13205-024-03925-8.
Natural compounds as lactate dehydrogenase inhibitors: potential therapeutics for lactate dehydrogenase inhibitors-related diseases.
Han J, Lee E, Park W, Ha K, Chung H
Front Pharmacol. 2023; 14:1275000.
PMID: 37915411
PMC: 10616500.
DOI: 10.3389/fphar.2023.1275000.
Cprp-An Unusual, Repetitive Protein Which Impacts Pleuromutilin Biosynthesis in the Basidiomycete .
de Mattos-Shipley K, Foster G, Bailey A
Front Fungal Biol. 2023; 2:655323.
PMID: 37744150
PMC: 10512284.
DOI: 10.3389/ffunb.2021.655323.
Identification of the Constituent Brusatol as a EGFR-Tyrosine Kinase Inhibitor in a Cell-Free Assay.
Suwattanasophon C, Mistlberger-Reiner A, Alberdi-Cedeno J, Pignitter M, Somoza V, Konig J
ACS Omega. 2023; 8(31):28543-28552.
PMID: 37576644
PMC: 10413460.
DOI: 10.1021/acsomega.3c02931.
Lipid-based nanoparticle-mediated combination therapy for breast cancer management: a comprehensive review.
Gupta P, Neupane Y, Aqil M, Kohli K, Sultana Y
Drug Deliv Transl Res. 2023; 13(11):2739-2766.
PMID: 37261602
DOI: 10.1007/s13346-023-01366-z.
Anticancer effect of involucrasin A on colorectal cancer cells by modulating the Akt/MDM2/p53 pathway.
Wei C, Du J, Shen Y, Wang Z, Lin Q, Chen J
Oncol Lett. 2023; 25(6):218.
PMID: 37153032
PMC: 10157355.
DOI: 10.3892/ol.2023.13804.
Inhibition of Acetylcholinesterase by Novel Lupinine Derivatives.
Schepetkin I, Nurmaganbetov Z, Fazylov S, Nurkenov O, Khlebnikov A, Seilkhanov T
Molecules. 2023; 28(8).
PMID: 37110594
PMC: 10146204.
DOI: 10.3390/molecules28083357.
Evolution of Natural Product Scaffolds as Potential Proteasome Inhibitors in Developing Cancer Therapeutics.
Mir R, Ahad Mir P, Uppal J, Chawla A, Patel M, Bardakci F
Metabolites. 2023; 13(4).
PMID: 37110167
PMC: 10142660.
DOI: 10.3390/metabo13040509.